Chroma Investing

Value Investing for beginning & small time investors and the value investing strategies of Graham & Klarman

ORXE – Ore Pharamceutical Holdings – NCAV pharma stock – Bought and Sold

On Tuesday I bought 1600 shares of ORXE, a Net Net pharma stock for $.30/share or $485.00 including the ChoiceTrade $5.00 commission, for the Small Investor Portfolio. I sold today at .40/share for a profit $150.00 or nearly 31% including commissions. This is not my usual trading style. But as much as this was a […]

  • Subscribe to Chroma Investing

    Subscribe
  • Categories

  • Archives